Professional Seasonal Analysis for Trading

Virax Biolabs Group Limited - Ordinary Shares (VRAX)

Seasonality Analysis

Stocks 4 Years Analyzed

Virax Biolabs Group Limited - Ordinary Shares Annual Seasonality Statistics

-73.12%
Avg Annual Return
18.1%
Avg Monthly Win Rate
2/12
Positive Months
4
Years Analyzed

Virax Biolabs Group Limited - Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -23.90%
0%
Very Weak
February -0.59%
25%
Very Weak
March -14.82%
0%
Very Weak
April -22.06%
0%
Very Weak
May 25.95%
33%
Weak
June -2.55%
33%
Very Weak
July -15.91%
25%
Very Weak
August BEST 50.75%
25%
Weak
September WORST -26.01%
25%
Very Weak
October -13.60%
25%
Very Weak
November -10.06%
0%
Very Weak
December -20.31%
25%
Very Weak

Virax Biolabs Group Limited - Ordinary Shares 2026 vs Historical Pattern

Current Position
13.94
Historical Avg Position
24.05
Deviation
-10.11
Performance
Significantly Below Average

Virax Biolabs Group Limited - Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for VRAX with overlay patterns, custom date ranges, and more.

Create Free Account

Virax Biolabs Group Limited - Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Virax Biolabs Group Limited - Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for VRAX across multiple timeframes.

Create Free Account

About Virax Biolabs Group Limited - Ordinary Shares (VRAX) Seasonality

Virax Biolabs Group Limited - Ordinary Shares (VRAX) has been analyzed using 4 years of historical data to identify seasonal patterns. Classified under Stocks, Virax Biolabs Group Limited - Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Virax Biolabs Group Limited - Ordinary Shares is historically August, with an average return of 50.75% and a win rate of 25%. Conversely, September tends to be the weakest month, averaging -26.01% return.

Looking at the full calendar year, Virax Biolabs Group Limited - Ordinary Shares has an average annual return of -73.12% with an overall monthly win rate of 18.1%. Out of 12 months, 2 typically show positive average returns.

The seasonal pattern for Virax Biolabs Group Limited - Ordinary Shares has a consistency score of 74.5 (Very Good), based on 5 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Virax Biolabs Group Limited - Ordinary Shares Seasonality FAQ

What is the best month to buy Virax Biolabs Group Limited - Ordinary Shares (VRAX)?

Historically, August has been the best month for Virax Biolabs Group Limited - Ordinary Shares, with an average return of 50.75% and a win rate of 25%. However, past performance does not guarantee future results.

What is the worst month for Virax Biolabs Group Limited - Ordinary Shares (VRAX)?

Based on historical data, September has been the weakest month for Virax Biolabs Group Limited - Ordinary Shares, with an average return of -26.01%. This is a historical observation and does not guarantee future results.

How reliable is VRAX seasonality data?

The seasonality analysis for Virax Biolabs Group Limited - Ordinary Shares is based on 4 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Virax Biolabs Group Limited - Ordinary Shares seasonality in my trading?

Use Virax Biolabs Group Limited - Ordinary Shares (VRAX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.